Schroder Investment Management Group
KYMR icon

Schroder Investment Management Group’s Kymera Therapeutics KYMR Stock Holding History

Schroder Investment Management Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Sell
27,997
-15,246
-35% -$1.31M ﹤0.01% 856
2026
Q1 		$3.44M Sell
43,243
-9,428
-18% -$747K ﹤0.01% 840
2025
Q4 		$4.11M Sell
52,671
-8,969
-15% -$606K ﹤0.01% 783
2025
Q3 		$3.61M Sell
61,640
-48,573
-44% -$2.19M ﹤0.01% 827
2025
Q2 		$4.81M Sell
110,213
-48,125
-30% -$1.66M ﹤0.01% 769
2025
Q1 		$4.69M Sell
158,338
-5,558
-3% -$203K ﹤0.01% 766
2024
Q4 		$6.44M Buy
163,896
+20,204
+14% +$913K 0.01% 725
2024
Q3 		$7M Sell
143,692
-18,509
-11% -$817K 0.01% 732
2024
Q2 		$4.84M Buy
162,201
+41,354
+34% +$1.43M 0.01% 789
2024
Q1 		$4.86M Sell
120,847
-64,452
-35% -$2.31M 0.01% 786
2023
Q4 		$4.72M Sell
185,299
-42,281
-19% -$756K 0.01% 775
2023
Q3 		$3.16M Buy
227,580
+2,749
+1% +$55.3K ﹤0.01% 839
2023
Q2 		$5.17M Buy
+224,831
New +$6.44M 0.01% 778
2022
Q1 		– Sell
-28,989
Closed -$1.84M – 1480
2021
Q4 		$1.84M Buy
+28,989
New +$1.69M ﹤0.01% 944

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Schroder Investment Management Group's KYMR Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Kymera Therapeutics (KYMR) stake by 35% in Q2 2026, selling an estimated $1.31M and leaving 27,997 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Schroder Investment Management Group first reported a position in KYMR in Q4 2021 and has held it in 14 quarters since. The position peaked at $7M in Q3 2024. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Schroder Investment Management Group held 27,997 shares of Kymera Therapeutics worth $3.06M as of Q2 2026.
  • Schroder Investment Management Group sold 15,246 Kymera Therapeutics shares in Q2 2026, an estimated $1.31M.
  • Kymera Therapeutics made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #856 holding.
  • Schroder Investment Management Group first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Schroder Investment Management Group's Kymera Therapeutics position peaked at $7M in Q3 2024.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.